LENSAR granted stock options to new employees

From GlobeNewswire: 2025-01-02 18:08:56

LENSAR, Inc. announced that three new non-executive employees were granted stock options to purchase 1,650 shares of the company’s common stock. The options have an exercise price of $8.69 per share and vest over time, with a 10-year term. LENSAR focuses on developing systems for cataract treatment and astigmatism management, including the ALLY Robotic Cataract Laser System™. The system aims to improve surgical efficiency and outcomes through advanced robotic technologies and AI integration. LENSAR’s Streamline® software guides surgeons to achieve better results in cataract surgery.



Read more at GlobeNewswire: LENSAR Reports Inducement Grants Under Nasdaq Listing Rule